[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE60015496D1 - Verfahren zur herstellung von 3-substituierte 1,5-diarylpyrozole - Google Patents

Verfahren zur herstellung von 3-substituierte 1,5-diarylpyrozole

Info

Publication number
DE60015496D1
DE60015496D1 DE60015496T DE60015496T DE60015496D1 DE 60015496 D1 DE60015496 D1 DE 60015496D1 DE 60015496 T DE60015496 T DE 60015496T DE 60015496 T DE60015496 T DE 60015496T DE 60015496 D1 DE60015496 D1 DE 60015496D1
Authority
DE
Germany
Prior art keywords
diarylpyrozoles
substituted
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60015496T
Other languages
English (en)
Other versions
DE60015496T2 (de
Inventor
F Abdel-Magid
D Harris
A Maryanoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE60015496D1 publication Critical patent/DE60015496D1/de
Publication of DE60015496T2 publication Critical patent/DE60015496T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/083Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid anhydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/88Unsaturated compounds containing keto groups containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60015496T 1999-08-03 2000-08-01 Verfahren zur herstellung von 3-substituierte 1,5-diarylpyrozole Expired - Lifetime DE60015496T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14699799P 1999-08-03 1999-08-03
US146997P 1999-08-03
PCT/US2000/020917 WO2001009102A2 (en) 1999-08-03 2000-08-01 Process for preparing 1,5-diaryl-3-substituted pyrazoles

Publications (2)

Publication Number Publication Date
DE60015496D1 true DE60015496D1 (de) 2004-12-09
DE60015496T2 DE60015496T2 (de) 2005-10-27

Family

ID=22519936

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60015496T Expired - Lifetime DE60015496T2 (de) 1999-08-03 2000-08-01 Verfahren zur herstellung von 3-substituierte 1,5-diarylpyrozole
DE60031315T Expired - Lifetime DE60031315T2 (de) 1999-08-03 2000-08-01 Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60031315T Expired - Lifetime DE60031315T2 (de) 1999-08-03 2000-08-01 Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure

Country Status (26)

Country Link
US (4) US6384233B1 (de)
EP (2) EP1413575B1 (de)
JP (2) JP4886951B2 (de)
KR (1) KR100646883B1 (de)
CN (1) CN1219771C (de)
AR (1) AR032589A1 (de)
AT (2) ATE342254T1 (de)
AU (2) AU779353B2 (de)
BR (1) BR0006978B1 (de)
CA (2) CA2636755C (de)
CZ (2) CZ299710B6 (de)
DE (2) DE60015496T2 (de)
DK (1) DK1413575T3 (de)
ES (2) ES2274171T3 (de)
HK (1) HK1040081B (de)
HU (1) HU228678B1 (de)
IL (2) IL142341A0 (de)
MY (1) MY122496A (de)
NO (1) NO318467B1 (de)
NZ (1) NZ510890A (de)
PL (1) PL201799B1 (de)
PT (2) PT1413575E (de)
RU (1) RU2243967C2 (de)
TW (1) TWI234562B (de)
WO (1) WO2001009102A2 (de)
ZA (1) ZA200103533B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1413575B1 (de) * 1999-08-03 2006-10-11 Ortho-McNeil Pharmaceutical, Inc. Verfahren zur Herstellung von Derivaten von ¬(1,5-Diaryl)pyrazol-3-yl|propansäure
WO2004089303A2 (en) * 2003-04-03 2004-10-21 Merck & Co., Inc. Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
WO2005019523A2 (en) * 2003-08-19 2005-03-03 Day-Glo Color Corp. Polymeric colorants and method of coloring thermoplastic resins
EP2805957A1 (de) 2013-05-23 2014-11-26 hameln rds gmbh Kristalline Formen von Trinatrium-Zink-Diethylen-triaminpentaessigsäure
CN111018785B (zh) * 2019-12-26 2022-02-11 武汉科技大学 一种1-(4-氯苯基)-3-吡唑醇的合成方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
US5164381A (en) 1986-05-29 1992-11-17 Ortho Pharmaceutical Corporation Pharmacologically active 1,5-diaryl-3-substituted pyrazoles and method for synthesizing the same
US5078780A (en) 1986-10-22 1992-01-07 Ciba-Geigy Corporation 1,5-diphenylpyrazole-3-carboxylic acid derivatives for the protection of cultivated plants
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition
US4898952A (en) * 1987-05-29 1990-02-06 Ortho Pharmaceutical Corporation Regioselective synthesis of a 1,5-disubstituted pyrazole
JPH0699382B2 (ja) * 1987-06-17 1994-12-07 富士写真フイルム株式会社 N−メチル−α−ジアルキルアミノアセトヒドロキサム酸誘導体
US5130421A (en) * 1988-03-24 1992-07-14 Bristol-Myers Company Production of 2',3'-dideoxy-2',3'-didehydronucleosides
US4896952A (en) * 1988-04-22 1990-01-30 International Business Machines Corporation Thin film beamsplitter optical element for use in an image-forming lens system
US5154381A (en) * 1988-12-02 1992-10-13 Malinao Michael M Microphone boom holder
US5032588A (en) * 1989-12-08 1991-07-16 Abbott Laboratories Thiazole lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
US5117054A (en) 1991-09-26 1992-05-26 Ortho Pharmaceutical Corporation N-hydroxy, N-methyl propanamides
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5387602A (en) 1993-08-30 1995-02-07 Ortho Pharmaceutical Corporation 1.5-diphenyl-3-(N-hydroxycarbamoyloxyalkyl)pyrazoles
US5412151A (en) * 1993-10-22 1995-05-02 Eastman Chemical Company Thermosetting coating compositions
JPH0944014A (ja) * 1995-08-03 1997-02-14 Canon Inc 加熱用フィルム、加熱加圧部材、加熱装置及び画像形成装置
US5843958A (en) * 1996-11-27 1998-12-01 Ortho Pharmaceutical Corporation Arylpyrazoles as leukotriene inhibitors
EP1413575B1 (de) * 1999-08-03 2006-10-11 Ortho-McNeil Pharmaceutical, Inc. Verfahren zur Herstellung von Derivaten von ¬(1,5-Diaryl)pyrazol-3-yl|propansäure

Also Published As

Publication number Publication date
NO20011652L (no) 2001-05-23
JP2003506359A (ja) 2003-02-18
HUP0103778A3 (en) 2002-07-29
CZ20011202A3 (cs) 2001-09-12
AR032589A1 (es) 2003-11-19
CN1219771C (zh) 2005-09-21
DK1413575T3 (da) 2006-12-27
CA2636755C (en) 2010-10-19
ZA200103533B (en) 2002-05-02
CZ299711B6 (cs) 2008-10-29
ES2232482T3 (es) 2005-06-01
BR0006978B1 (pt) 2010-11-30
EP1144382A2 (de) 2001-10-17
EP1413575A2 (de) 2004-04-28
NZ510890A (en) 2003-09-26
WO2001009102A2 (en) 2001-02-08
US20020128487A1 (en) 2002-09-12
US6384233B1 (en) 2002-05-07
EP1413575A3 (de) 2004-10-06
DE60031315D1 (de) 2006-11-23
EP1413575B1 (de) 2006-10-11
PT1144382E (pt) 2005-02-28
EP1144382A3 (de) 2002-09-11
AU779353B2 (en) 2005-01-20
IL171712A (en) 2010-04-29
RU2243967C2 (ru) 2005-01-10
US20040230060A1 (en) 2004-11-18
HUP0103778A2 (hu) 2002-05-29
AU2005201660A1 (en) 2005-05-12
MY122496A (en) 2006-04-29
KR20010075571A (ko) 2001-08-09
PT1413575E (pt) 2006-12-29
US20020032336A1 (en) 2002-03-14
HK1040081B (zh) 2005-05-13
CA2346142A1 (en) 2001-02-08
DE60015496T2 (de) 2005-10-27
JP4886951B2 (ja) 2012-02-29
AU6752600A (en) 2001-02-19
HK1040081A1 (en) 2002-05-24
JP2012051929A (ja) 2012-03-15
US20060004208A1 (en) 2006-01-05
CN1337951A (zh) 2002-02-27
EP1413575A9 (de) 2005-06-29
KR100646883B1 (ko) 2006-11-17
TWI234562B (en) 2005-06-21
CA2636755A1 (en) 2001-02-08
CA2346142C (en) 2008-10-14
IL142341A0 (en) 2002-03-10
BR0006978A (pt) 2001-06-19
CZ299710B6 (cs) 2008-10-29
ES2274171T3 (es) 2007-05-16
ATE342254T1 (de) 2006-11-15
US6613914B2 (en) 2003-09-02
US6953860B2 (en) 2005-10-11
PL347025A1 (en) 2002-03-11
US7247745B2 (en) 2007-07-24
ATE281437T1 (de) 2004-11-15
DE60031315T2 (de) 2007-04-26
PL201799B1 (pl) 2009-05-29
NO20011652D0 (no) 2001-04-02
NO318467B1 (no) 2005-03-21
EP1144382B1 (de) 2004-11-03
HU228678B1 (en) 2013-05-28
WO2001009102A3 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
DE69801489D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69915878D1 (de) Verfahren zur herstellung von 2,3-dihalogenpropanolen
DE69711669D1 (de) VERFAHREN ZUR HERSTELLUNG VON d,1-ALPHA-TOCOPHEROL
DE60003264D1 (de) Verfahren zur herstellung von glycerylethern
DE59906265D1 (de) Verfahren zur herstellung von 1,4-butandiol
DE59901552D1 (de) Verfahren zur herstellung von polyalkylenarylaten
DE50006772D1 (de) Verfahren zur herstellung von oxindolen
DE59905197D1 (de) Verfahren zur herstellung von hexandiol-1,6
DE50001895D1 (de) Verfahren zur herstellung von phosphonomethylglycin
ATE241588T1 (de) Verfahren zur herstellung von 3,5-difluoroanilin
ATE296850T1 (de) Verfahren zur herstellung von polyamiden
ATE366251T1 (de) Verfahren zur herstellung von 1,3- disubstituierten-4-oxocyclischen harnstoffen
DE60015496D1 (de) Verfahren zur herstellung von 3-substituierte 1,5-diarylpyrozole
ATE267839T1 (de) Verfahren zur herstellung von cyclo-(asp-dphe- nmeval-arg-gly)
ATE233238T1 (de) Verfahren zur herstellung von 3-acyl-indolen
DE69928784D1 (de) Verfahren zur herstellung von oxazolidin-2-on-derivaten
ATE275563T1 (de) Verfahren zur herstellung von 1,3- disubstituierten-4-oxocyclischen harnstoffen
ATE234337T1 (de) Verfahren zur herstellung von polyamiden
ATE295349T1 (de) Verfahren zur herstellung von ketiminen
ATE264829T1 (de) Verfahren zur herstellung von acylierten 1,3- dicarbonylverbindungen
DE69918337D1 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalen
DE60011427D1 (de) Verfahren zur herstellung von 2-pyridylpiperidin-derivaten
DE59906901D1 (de) Verfahren zur herstellung von 1-substituierten 5-hydroxypyrazolen
DE59903764D1 (de) Verfahren zur herstellung von phytosqualan
DE50004440D1 (de) Verfahren zur herstellung von phosphonomethylglycin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN